Posted: 5/8/2019
Update as of 5/30/2019
Updated as of 5/30/2019
| 5/30/2019 | May 28, 2019 Untitled Letter - R3 Stem Cell, LLC |
| 5/30/2019 | Science and Regulation of Live Microbiome-Based Products Used to Prevent, Treat, or Cure Diseases in Humans Update as of 5/30/2019 |
| 5/30/2019 | Exceptions and Alternative Procedures Approved Under 21 CFR 640.120 Updated as of 5/30/2019 |
| 5/29/2019 | Standards Development for Regenerative Medicine Therapies |
| 5/29/2019 | Resources Related to Regenerative Medicine Therapies |
| 5/28/2019 | May 24, 2019 Approval Letter - ActHIB |
| 5/24/2019 | May 24, 2019 Approval Letter - ZOLGENSMA |
| 5/24/2019 | BK190332 - Trima Accel Automated Blood Collection System |
| 5/23/2019 | May 22, 2019 Approval Letter - Intersol Solution/Platelet Additive Solution 3 |
| 5/21/2019 | Framework for the Regulation of Regenerative Medicine Products Updated as of 5/21/2019 |
.png)
No hay comentarios:
Publicar un comentario